The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
A possible role for humoral immunity in the pathogenesis of Parkinson's disease
Abstract
The pathogenesis of idiopathic Parkinson's disease is unknown, but nigral degeneration and depigmentation are associated with microglial inflammation and anti-inflammatory medications appear to protect against the disease. The possibility that humoral immunity may play a role in initiating or regulating the inflammation has been suggested by experimental studies triggering dopamine cell death using a variety of transfer strategies and the observation of CD8+ T lymphocytes and complement in the nigra in Parkinson's disease. We analysed the association between degeneration and humoral immune markers in brain tissue of patients with idiopathic (n = 13) or genetic (n = 2 with alpha-synuclein and n = 1 with parkin mutations) Parkinson's disease and controls without neurological disease (n = 12) to determine the humoral immune involvement in Parkinson's disease. Formalin-fixed tissue samples from the substantia nigra and primary visual cortex for comparison were stained for alpha-synuclein, major histocompatibility complex II (HLA), immunoglobulin M (IgM), immunoglobulin G (IgG), IgG subclasses 1-4 and IgG receptors FcgammaR I-III. Antigen retrieval and both single immunoperoxidase and double immunofluorescence procedures were employed to determine the cell types involved and their pattern and semiquantitative densities. Significant dopamine neuron loss occurred in all patients with Parkinson's disease, negatively correlating with disease duration (r = -0.76, P = 0.002). Although all patients had increased inflammatory HLA immunopositive microglia, the degree of inflammation was similar throughout the disease (r = 0.08, P = 0.82). All patients with Parkinson's disease had IgG binding on dopamine neurons but not IgM binding. Lewy bodies were strongly immunolabelled with IgG. A mean 30 +/- 12% of dopamine nigral neurons were immunoreactive for IgG in Parkinson's disease with the proportion of IgG immunopositive neurons negatively correlating with the degree of cell loss in the substantia nigra (r = -0.67, P < 0.0001) and positively correlating with the number of HLA immunopositive microglia (r = 0.51, P = 0.01). Most neuronal IgG was the IgG1 subclass with some IgG3 and less IgG2 also found in the damaged substantia nigra. The high affinity activating IgG receptor, FcgammaRI, was expressed on nearby activated microglia. The low affinity activating IgG receptor, FcgammaRIII was expressed on cells morphologically resembling lymphocytes, whereas immunoreactivity for the inhibitory IgG receptor FcgammaRII was absent in all cases. This pattern of humoral immune reactivity is consistent with an immune activation of microglia leading to the targeting of dopamine nigral neurons for destruction in both idiopathic and genetic cases of Parkinson's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Microglia: a sensor for pathological events in the CNS
Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396
AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITY
FEARNLEY, J. M., & LEES, A. J. (1991) · Brain · doi:10.1093/brain/114.5.2283 · Cited by 3,529
McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
Diagnostic Criteria for Parkinson Disease
Gelb, D. J., Oliver, E., & Gilman, S. (1999) · Archives of Neurology · doi:10.1001/archneur.56.1.33 · Cited by 2,822
Aloisi, F. (2001) · Glia · doi:10.1002/glia.1106 · Cited by 1,280
Wu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D.-K., Ischiropoulos, H., & Przedborski, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01763.2002 · Cited by 1,183 · cited 2×
“Direct inhibition of microglial activation (He et al., 2001; Liu et al., 2000; Wu et al., 2002) or therapeutic immunization using adoptive transfer of immune cells (Benner et al., 2004; Boska et al., 2005) is neuroprotective in these models.”
MethodKim, W.-G., Mohney, R. P., Wilson, B., Jeohn, G.-H., Liu, B., & Hong, J.-S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-16-06309.2000 · Cited by 878
Microglial activation and dopamine terminal loss in early Parkinson's disease
Ouchi, Y., Yoshikawa, E., Sekine, Y., Futatsubashi, M., Kanno, T., Ogusu, T., & Torizuka, T. (2005) · Annals of Neurology · doi:10.1002/ana.20338 · Cited by 843
Imamura, K., Hishikawa, N., Sawada, M., Nagatsu, T., Yoshida, M., & Hashizume, Y. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0766-2 · Cited by 791 · cited 1×
“The degree of cell loss and reactive microgliosis were similar to those previously described for similar case types (Fearnley and Lees, 1991; Imamura et al., 2003).”
ResultBlood–brain barrier dysfunction in parkinsonian midbrain in vivo
Kortekaas, R., Leenders, K. L., van Oostrom, J. C. H., Vaalburg, W., Bart, J., Willemsen, A. T. M., & Hendrikse, N. H. (2005) · Annals of Neurology · doi:10.1002/ana.20369 · Cited by 733
Gao, H., Jiang, J., Wilson, B., Zhang, W., Hong, J., & Liu, B. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00928.x · Cited by 687
Nonsteroidal Anti-inflammatory Drugs and the Risk of Parkinson Disease
Chen, H., Zhang, S. M., Hernán, M. A., Schwarzschild, M. A., Willett, W. C., Colditz, G. A., Speizer, F. E., & Ascherio, A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1059 · Cited by 634
Spira, P. J., Sharpe, D. M., Halliday, G., Cavanagh, J., & Nicholson, G. A. (2001) · Annals of Neurology · doi:10.1002/ana.67 · Cited by 627
Self-citationDistinct Role for Microglia in Rotenone-Induced Degeneration of Dopaminergic Neurons
Gao, H.-M., Hong, J.-S., Zhang, W., & Liu, B. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-03-00782.2002 · Cited by 439
Glial pathology but absence of apoptotic nigral neurons in long‐standing Parkinson's disease
Banati, R. B., Daniel, S. E., & Blunt, S. B. (1998) · Movement Disorders · doi:10.1002/mds.870130205 · Cited by 431
Neuroinflammatory processes in Parkinson's disease
Hunot, S., & Hirsch, E. C. (2003) · Annals of Neurology · doi:10.1002/ana.10481 · Cited by 398
He, Y., Appel, S., & Le, W. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02681-6 · Cited by 348
Liu, B., Du, L., & Hong, J.-S. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39275-4 · Cited by 347 · cited 2×
“Direct inhibition of microglial activation (He et al., 2001; Liu et al., 2000; Wu et al., 2002) or therapeutic immunization using adoptive transfer of immune cells (Benner et al., 2004; Boska et al., 2005) is neuroprotective in these models.”
MethodSpira, P. J., Sharpe, D. M., Halliday, G. M., Cavanagh, J., & Nicholson, G. A. (2001) · PubMed · Cited by 343
Self-citationMirza, B., Hadberg, H., Thomsen, P., & Moos, T. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00455-8 · Cited by 327
Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease
Benner, E. J., Mosley, R. L., Destache, C. J., Lewis, T. B., Jackson-Lewis, V., Gorantla, S., Nemachek, C., Green, S. R., Przedborski, S., & Gendelman, H. E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400569101 · Cited by 321
An inflammatory review of Parkinson's disease
Orr, C. F., Rowe, D. B., & Halliday, G. M. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00127-2 · Cited by 309
Self-citationA one-hit model of cell death in inherited neuronal degenerations
Clarke, G., Collins, R. A., Leavitt, B. R., Andrews, D. F., Hayden, M. R., Lumsden, C. J., & McInnes, R. R. (2000) · Nature · doi:10.1038/35018098 · Cited by 303
Autoimmunity due to molecular mimicry as a cause of neurological disease
Levin, M. C., Lee, S. M., Kalume, F., Morcos, Y., Dohan, F. C., Hasty, K. A., Callaway, J. C., Zunt, J., Desiderio, D. M., & Stuart, J. M. (2002) · Nature Medicine · doi:10.1038/nm0502-509 · Cited by 264
Lewy bodies in Parkinson's disease are recognized by antibodies to complement proteins
Yamada, T., McGeer, P. L., & McGeer, E. G. (1992) · Acta Neuropathologica · doi:10.1007/bf00427222 · Cited by 231
Inflamm-aging: autoimmunity, and the immune-risk phenotype
Boren, E., & Gershwin, M. E. (2004) · Autoimmunity Reviews · doi:10.1016/j.autrev.2004.03.004 · Cited by 222
The Immune System in the Elderly: Activation-Induced and Damage-Induced Apoptosis
Ginaldi, L., De Martinis, M., Monti, D., & Franceschi, C. (2004) · Immunologic Research · doi:10.1385/ir:30:1:081 · Cited by 202
Lindersson, E., Lundvig, D., Petersen, C., Madsen, P., Nyengaard, J. R., Højrup, P., Moos, T., Otzen, D., Gai, W.-P., Blumbergs, P. C., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410409200 · Cited by 196
Flügel, A., Bradl, M., Kreutzberg, G. W., & Graeber, M. B. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1198 · Cited by 169
The immune S ystem in the elderly
Ginaldi, L., Martinis, M. D., D’Ostilio, A., Marini, L., Loreto, M. F., Martorelli, V., & Quaglino, D. (1999) · Immunologic Research · doi:10.1007/bf02786467 · Cited by 139
Ulvestad, E., Williams, K. C., Matre, R., Nyland, H., Olivier, A., & Antel, J. P. (1994) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199401000-00004 · Cited by 137
The immune system in the elderly: III. Innate Immunity
Ginaldi, L., Martinis, M. D., D’Ostilio, A., Marini, L., Loreto, M. F., & Quaglino, D. (1999) · Immunologic Research · doi:10.1007/bf02786468 · Cited by 130
Parkin and Parkinsonʼs disease
Mizuno, Y., Hattori, N., Mori, H., Suzuki, T., & Tanaka, K. (2001) · Current Opinion in Neurology · doi:10.1097/00019052-200108000-00008 · Cited by 126
Self-citationKurkowska‐Jastrzębska, I., Wrońska, A., Kohutnicka, M., Członkowski, A., & Członkowska, A. (1999) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-1999-1289 · Cited by 125
The immune S ystem in the elderly: I. Specific Humoral Immunity
Ginaldi, L., Martinis, M. D., D’Ostitio, A., Marini, L., Loreto, M. F., Corsi, M., & Quaglino, D. (1999) · Immunologic Research · doi:10.1007/bf02786466 · Cited by 121
Midbrain neuropathology in idiopathic Parkinson's disease and diffuse Lewy body disease
Halliday, G. M., McRitchie, D. A., Cartwright, H., Pamphlett, R., Hely, M. A., & Morris, J. G. (1996) · Journal of Clinical Neuroscience · doi:10.1016/s0967-5868(96)90083-1 · Cited by 115
Self-citationAdd Alzheimer's disease to the list of autoimmune diseases
D’Andrea, M. R. (2005) · Medical Hypotheses · doi:10.1016/j.mehy.2004.08.024 · Cited by 113
He, Y., Le, W., & Appel, S. H. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.7946 · Cited by 97
Overmyer, M., Helisalmi, S., Soininen, H., Laakso, M., Riekkinen Sr., P., & Alafuzoff, I. (1999) · Acta Neuropathologica · doi:10.1007/s004010051002 · Cited by 91 · cited 2×
“The activation of microglia in the SN in Parkinson's disease is not a generalized inflammatory response in the brain, but is highly localized (see also Ouchi et al., 2005), contrasting with the overall small increase in the immune response of microglia to ageing (Overmyer et al., 1999).”
BackgroundGenetic contributions to Parkinson's disease
Huang, Y. M., Cheung, L., Rowe, D. B., & Halliday, G. M. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.04.007 · Cited by 91
Self-citationCortical Inflammation in Alzheimer Disease but Not Dementia With Lewy Bodies
Shepherd, C. E., Thiel, E., McCann, H., Harding, A. J., & Halliday, G. M. (2000) · Archives of Neurology · doi:10.1001/archneur.57.6.817 · Cited by 73
Self-citationBoska, M. D., Lewis, T. B., Destache, C. J., Benner, E. J., Nelson, J. A., Uberti, M., Mosley, R. L., & Gendelman, H. E. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.4364-04.2005 · Cited by 72
Neuronal molecular mimicry in immune‐mediated neurologic disease
Levin, M. C., Krichavsky, M. Z., Berk, J., Foley, S., Rosenfeld, M. R., Dalmau, J. O., Chang, G., Posner, J. B., & Jacobson, S. (1998) · Annals of Neurology · doi:10.1002/ana.410440115 · Cited by 69
Circulating Autoantibodies Recognize and Bind Dying Neurons Following Injury to the Brain
Stein, T. D., Fedynyshyn, J. P., & Kalil, R. E. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.12.1100 · Cited by 51
Integrity of the blood–cerebrospinal fluid barrier in early Parkinson's disease
Häussermann, P., Kuhn, W., Przuntek, H., & Müller, T. H. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01574-9 · Cited by 42
Kalume, F. K., Lee, S. M., Morcos, Y., Callaway, J. C., & Levin, M. C. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20137 · Cited by 41
IgG in brain correlates with clinicopathological damage in HTLV-1 associated neurologic disease
Jernigan, M., Morcos, Y., Lee, S. M., Dohan, F. C., Raine, C. S., & Levin, M. C. (2003) · Neurology · doi:10.1212/01.wnl.0000059866.03880.ba · Cited by 33
Defazio, G., Toso, R. D., Benvegnuù, D., MINOZZI, M. C., Cananzi, A. R., & Leon, A. (1994) · Brain Research · doi:10.1016/0006-8993(94)91541-5 · Cited by 33
Experimental autoimmune nigral damage in guinea pigs
Le, W. D., Engelhardt, J., Xie, W., et al. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(94)00160-p · Cited by 28
Nigral damage and dopaminergic hypofunction in mesencephalon‐immunized guinea pigs
Appel, S. H., Le, W., Tajti, J., Haverkamp, L. J., & Engelhardt, J. I. (1992) · Annals of Neurology · doi:10.1002/ana.410320403 · Cited by 28
Cited by
-Synuclein in Parkinson's Disease
Stefanis, L. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009399 · Cited by 1,446
Inflammation and immune dysfunction in Parkinson disease
Tansey, M. G., Wallings, R. L., Houser, M. C., Herrick, M. K., Keating, C. E., & Joers, V. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-022-00684-6 · Cited by 1,382
Microglia development and function
Nayak, D., Roth, T. L., & McGavern, D. B. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120240 · Cited by 1,154
Autophagy and apoptosis dysfunction in neurodegenerative disorders
Ghavami, S., Shojaei, S., Yeganeh, B., Ande, S. R., Jangamreddy, J. R., Mehrpour, M., Christoffersson, J., Chaabane, W., Moghadam, A. R., Kashani, H. H., et al. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.10.004 · Cited by 1,039
Calabresi, P., Mechelli, A., Natale, G., Volpicelli-Daley, L., Di Lazzaro, G., & Ghiglieri, V. (2023) · Cell Death & Disease · doi:10.1038/s41419-023-05672-9 · Cited by 817
Metadata
- Authors
- Orr, C. F., Rowe, D. B., Mizuno, Y., Mori, H., & Halliday, G. M.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-10-11
- Volume
- 128
- Issue
- 11
- Pages
- 2665-2674
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2165339984
- Cited by
- 350
- References
- 50
- FWCI
- 7.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.